Community-based intervention has lasting benefits, trial follow-up shows. The success of a barbershop intervention to tackle uncontrolled blood pressure (BP) among African-American men persisted at 12 months, mirroring 6-month findings of the randomized…
The Association of Black Cardiologists collaborating with Quantum Genomics’ NEW-HOPE Study, incorporating minority inclusivity, presents Late-Breaking Trial success of novel antihypertensive agent. Firibastat meets primary endpoint and demonstrates highly significant…
by Foluso Fakorede, MD on tackling the epidemic of PAD among minorities In 1966, Dr. Martin Luther King, Jr., observed: “Of all the forms of inequality, injustice in healthcare is the most…
STAT (11/2, Cooney) reported that research “examining how long black or white people survive after a heart attack concludes that it’s socioeconomic status, far more than race, that explains who fares…
Comment: “While clinicians cannot specifically control how the pharmaceutical industry sets prices for medications, we welcome any steps that increase access to agents to prevent cardiovascular events in patients with established…
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices. (New York Times article, October 2, 2018)
